Search
for
Sort by
Research 61–90 of 351
- TNF-a in nonscarring inflammatory alopecia
- Topical botanical extract for management of chemotherapy-induced alopecia
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Efficacy of stem cell therapy for burn wounds: a systematic review and meta-analysis of preclinical studies
- Taste disorders and alopecia in myasthenia gravis
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Abstracts
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Electron beam tomography quantitation of coronary calcium and assessment for ischemic coronary disease: a complement to stress testing
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040
- Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Effects of oral minoxidil on serum VEGF and hair regrowth in androgenetic alopecia
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Effects of Hair Follicle Stem Cells on Partial-Thickness Burn Wound Healing and Tensile Strength
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Androgens in SARS-CoV-2 Coronavirus Infections
- Construction of regulatory network for alopecia areata progression and identification of immune monitoring genes based on multiple machine-learning algorithms
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database